DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Ågerup family family
Uppsala, Sweden
Data as of (this record's last observation) from federal regulator filings, dfx's own graph. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Target | State | Kind | Asset class | Sector | Announced | Amount | Evidence |
|---|---|---|---|---|---|---|---|
| Oasmia Pharmaceutical AB | n/a | equity | pharmaceutical | life sciences | Jan 15, 2013 | n/a | fact |
| Olink AB | n/a | equity | healthcare/proteomics | life sciences | Aug 29, 2011 | n/a | fact |
| Q-linea AB | n/a | equity, majority stake plus loan facility | medtech | life sciences | n/a | n/a | fact |
| Person | Title | Role | Seniority | Family member | Current | Evidence |
|---|---|---|---|---|---|---|
| Erika Kjellberg Eriksson | CEO and Chair of the Board | leadership | senior | no | yes | fact |
| Per-Olof Wallström | Member of the Board | board | unknown | no | yes | fact |
| Angelica Loskog | Scientific Adviser | other | unknown | no | yes | fact |
| Bengt Ågerup | Founder | Family principal | senior | yes | yes | fact |
| Jon Heimer | Partner | leadership | senior | n/a | no | fact |
Also named here, with no published line of their own (reach them through the firm): Bengt Ågerup (Founder), Angelica Loskog (Scientific Adviser), Per-Olof Wallström (Member of the Board), Erika Kjellberg Eriksson (CEO and Chair of the Board).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan